7946 View: Overview

Glossary  HistCite Guide

Author(s) Suzuki Y Title Sialobiology of influenza molecular mechanism of host range variation of influenza viruses Source BIOLOGICAL & PHARMACEUTICAL BULLETIN 28 (3): 399-408 Date 2005 MAR Type Journal : Review LCR: 6   NCR: 99   LCS: 0   GCS: 0 Comment   Address Univ Shizuoka, Sch Pharmaceut Sci, Dept Biochem, Shizuoka 4228526, Japan. Reprint Suzuki, Y, Univ Shizuoka, Sch Pharmaceut Sci, Dept Biochem, 395 Yada, Shizuoka 4228526, Japan. E-mail suzukiy@u-shizuoka-ken.ac.jp Abstract The gene pool of influenza A viruses in aquatic birds provides all of the genetic diversity required for human and lower animals. Host range selection of the receptor binding specificity of the influenza virus hemagglutinin occurs during maintenance of the virus in different host cells that express different receptor sialo-sugar chains. In this paper, functional roles of the hemagglutinin and neuraminidase spikes of influenza viruses are described in the relation to 1) host range of influenza viruses, 2) receptor binding specificity of human and other animal influenza viruses, 3) recognition of sialyl sugar chains by Spanish influenza virus hemagglutinin, 4) highly pathogenic and potentially pandemic H5N1, H9N2, and H7N7 avian influenza viruses and molecular mechanism of host range variation of influenza viruses, 5) role of the neuraminidase spike for the host range of influenza viruses, and 6) Development of anti-influenza drugs. CR 1997, MORBID MORTAL WKLY R, V46, P1204 BASLER CF, 2001, P NATL ACAD SCI USA, V98, P2746 BAUM JG, 1990, ACTA HISTOCHEM S40, P35 BLICK TJ, 1995, VIROLOGY, V214, P475 BURNET FM, 1947, AUST J EXP BIOL MED, V25, P227 CAUTHEN AN, 2000, J VIROL, V74, P6592 CHOI YK, 2004, J VIROL, V78, P8609 CLAAS ECJ, 1998, LANCET, V351, P472 CROSBY AW, 1989, AM FORGOTTEN PLAQUE FLEMING DM, 2001, INT J CLIN PRACT, V55, P189 FOUCHIER RAM, 2004, P NATL ACAD SCI USA, V101, P1356 FUJIMOTO K, 1999, CHEM LETT DEC, P1259 FURUIKE T, 2000, J CHEM SOC PERK T 1, P3000 GAMBLIN SJ, 2004, SCIENCE, V303, P1838 GOTTSCHALK A, 1957, BIOCHIM BIOPHYS ACTA, V23, P645 GOTTSCHALK A, 1960, CHEM BIOL SIALIC ACI GUAN Y, 2002, P NATL ACAD SCI USA, V99, P8950 GUAN Y, 2004, P NATL ACAD SCI USA, V101, P8156 GUBAREVA LV, 2000, LANCET, V355, P827 GUO CT, 1998, GLYCOCONJUGATE J, V15, P1099 GUO CT, 2002, GLYCOBIOLOGY, V12, P183 HAYDEN FG, 1992, CURR TOP MICROBIOL, V176, P119 HAYDEN FG, 1996, ANTIVIRAL DRUG RESIS HINSHAW VS, 1983, VIROLOGY, V128, P260 HIRST GK, 1942, J EXP MED, V76, P195 HOLLAND J, 1982, SCIENCE, V215, P1577 HOSAKA Y, 1998, J ELECTRON MICROSC, V47, P169 HOSAKA Y, 2000, J ELECTRON MICROSC, V49, P765 HUGHES MT, 2001, J VIROL, V75, P3766 IKEDA K, 2001, CARBOHYD RES, V330, P31 ITO T, 1997, J VIROL, V71, P3357 ITO T, 1997, VIROLOGY, V227, P493 ITO T, 1998, J VIROL, V72, P7367 ITO T, 2000, J VIROL, V73, P6743 KAMITAKAHARA H, 1998, ANGEW CHEM INT EDIT, V37, P1724 KARASIN AI, 2000, VIRUS RES, V68, P71 KEAWCHAROEN J, 2004, EMERG INFECT DIS, V10 KISO M, 2004, LANCET, V364, P759 KOBASA D, 2001, J VIROL, V75, P11773 KOBASA D, 2004, NATURE, V431, P703 KOJIMA S, 2003, CHEM COMMUN, V11, P1250 KOOPMANS M, 2004, LANCET, V363, P587 KUIKEN T, 2004, SCIENCE, V306, P241 LI KS, 2004, NATURE, V430, P209 LIPATOV AS, 2004, J VIROL, V78, P8951 MATROSOVICH M, 1999, J VIROL, V73, P1146 MATROSOVICH MN, 2001, VIROLOGY, V281, P156 MATROSOVICH MN, 2004, J VIROL, V78, P12665 MATROSOVICH MN, 2004, P NATL ACAD SCI USA, V101, P4620 MCKIMMBRESCHKIN JL, 2000, ANTIVIR RES, V47, P1 MENDEL DB, 1998, ANTIMICROB AGENTS CH, V42, P640 NAKATA K, 2000, J BIOCHEM-TOKYO, V127, P191 NEUMANN G, 1999, P NATL ACAD SCI USA, V96, P9345 OHTA T, 2003, ANGEW CHEM INT EDIT, V42, P586 OSTERHAUS ADME, 2000, SCIENCE, V288, P1051 PEIRIS JSM, 2001, J VIROL, V75, P9679 PEIRIS JSM, 2004, LANCET, V363, P617 PYANPOIRIER K, 1998, VIRUS RES, V56, P169 READING PC, 2000, J VIROL, V74, P5190 REID AH, 2000, P NATL ACAD SCI USA, V97, P6785 SAITO T, 2001, VACCINE, V20, P125 SASAKI K, 2004, BIOORGAN MED CHEM, V12, P1367 SCHOLTISSEK C, 1990, MED PRIN PRACT, V2, P65 SCHULTZ U, 1991, VIROLOGY, V183, P61 SIDWELL RW, 1998, ANTIVIR RES, V37, P107 STASCHKE KA, 1995, VIROLOGY, V214, P642 STEINHAUER DA, 1987, ANNU REV MICROBIOL, V41, P409 STEVENS J, 2004, SCIENCE, V303, P1866 STRAY SJ, 2000, GLYCOBIOLOGY, V10, P649 SUBBARAO K, 1998, SCIENCE, V279, P393 SUN XL, 2000, EUR J ORG CHEM JUL, P2643 SUZUKI T, 1996, BIOCHEM J 2, V318, P389 SUZUKI T, 1997, FEBS LETT, V404, P192 SUZUKI T, 2003, FEBS LETT, V553, P355 SUZUKI T, 2004, INT CONGR SER, V1263, P781 SUZUKI Y, 1985, J BIOL CHEM, V260, P1362 SUZUKI Y, 1985, VACCINE, V3, P201 SUZUKI Y, 1986, J BIOL CHEM, V261, P7057 SUZUKI Y, 1989, J VIROL, V63, P4298 SUZUKI Y, 1992, VIROLOGY, V189, P121 SUZUKI Y, 1994, PROG LIPID RES, V33, P429 SUZUKI Y, 2000, J VIROL, V74, P11825 SUZUKI Y, 2002, RECENT ADV INFLUENZA, P161 TAI CY, 1998, ANTIMICROB AGENTS CH, V42, P3234 TAKAHASHI T, 2001, J BIOCHEM, V130, P279 TAKAHASHI T, 2003, FEBS LETT, V543, P71 TAUBENBERGER JK, 2000, VIROLOGY, V274, P241 TAUBENBERGER JK, 2001, PHILOS T ROY SOC B, V356, P1829 TOTANI K, 2003, GLYCOBIOLOGY, V13, P315 TSUCHIDA A, 1998, GLYCOCONJUGATE J, V15, P1047 VARKI A, 1999, ESSENTIALS GLYCOBIOL VISESHAKUL N, 2004, VIROLOGY, V328, P169 VONITZSTEIN M, 1993, NATURE, V363, P418 WANG C, 1993, J VIROL, V67, P5585 WEBSTER RG, 1992, MICROBIOL REV, V56, P152 WEBSTER RG, 2001, SCIENCE, V293, P1773 WEBSTER RG, 2002, J VIROL, V76, P118 XU GY, 1994, J BIOCHEM-TOKYO, V115, P202 XU GY, 1996, BIOCHEM BIOPH RES CO, V224, P815